China National Medicines sees board, executive departures

China National Medicines Corp has announced significant changes to its board and executive leadership. Effective immediately, directors Jiang Xin, Tian Guotao, and Wen Deyong have resigned from their positions. Jiang Xin, citing retirement, also relinquishes her roles as Chairman of the Strategic Committee, member of the Nomination Committee, and acting Chairman. Tian Guotao steps down as Director and General Manager due to a job change, and will no longer serve as the legal representative of the company. Wen Deyong also resigns from his directorship and committee memberships due to a job change. The company will hold a shareholder's meeting on July 7, 2025 to elect replacement directors, with shareholders of record as of June 26, 2025 being eligible to vote. The company expressed its gratitude to the departing executives for their contributions.